Anne‐Marie C. Dingemans
Researcher Next ID · RN-033944
Researcher · Medicine
Rotterdam, Netherlands
- Works count
- 659
- Citation count
- 21,580
- H-index
- 72
- i10-index
- 266
Research interests
Publications
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2307980
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
The Lancet · 2023 · 10.1016/s0140-6736(23)00221-0
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.02.003
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology · 2021 · 10.1016/j.annonc.2021.03.207
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30154-5
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
European Journal of Cancer · 2020 · 10.1016/j.ejca.2020.06.019
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30314-4
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30718-1
Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Journal of Thoracic Oncology · 2019 · 10.1016/j.jtho.2019.02.009
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
Nature Communications · 2019 · 10.1038/s41467-019-11276-9
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
Journal of Thoracic Oncology · 2019 · https://doi.org/10.1016/j.jtho.2019.07.025
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Clinical Cancer Research · 2017 · 10.1158/1078-0432.ccr-17-1921
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
Journal of Thoracic Oncology · 2016 · 10.1016/j.jtho.2016.10.003
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
Thorax · 2015 · 10.1136/thoraxjnl-2014-206677
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70168-3
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.58.3302
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
Oncotarget · 2015 · 10.18632/oncotarget.6279
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
Journal of Thoracic Oncology · 2012 · 10.1097/jto.0b013e318262caf6
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
Radiotherapy and Oncology · 2009 · 10.1016/j.radonc.2009.03.006
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
Annals of Oncology · 2008 · 10.1093/annonc/mdn559
Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation
American Review of Respiratory Disease · 1993 · 10.1164/ajrccm/147.5.1151
Current projects
No projects listed.